Pure Global AI
Manufacturer profile

HYPHEN BIOMED.

IndonesiaFrance9 products registered
VerifiedKemenkes (Ministry of Health) · official registry
9
Total Products
9
Product Names
1
Product Classes
1
Risk Classes
Regulatory footprint
Search HYPHEN BIOMED. across other regulatory registries
ThailandEuropean UnionColombiaSouth KoreaCanadaEcuador
Risk classification breakdown
Distribution of products across risk classes
Kelas Resiko : B9100.0% of total
Product class portfolio
Products organized by product class
Kelas : 2
BIOPHEN Rivaroxaban Plasma Calibrator, BIOPHEN Rivaroxaban Control Plasma, BIOPHEN™ DiXaI, REVOHEM Collagen, HEMOCLOT Thrombin Inhibitors ... and 4 more products in this class
9 Products
Recent registrations (9 most recent)
Most recently registered products with Ministry of Health
BIOPHEN Rivaroxaban Plasma Calibrator
Apr 29, 2024
Class
Kelas : 2
Risk Class
Kelas Resiko : B
BIOPHEN Rivaroxaban Control Plasma
Apr 19, 2024
Class
Kelas : 2
Risk Class
Kelas Resiko : B
BIOPHEN™ DiXaI
Sep 7, 2023
Class
Kelas : 2
Risk Class
Kelas Resiko : B
REVOHEM Collagen
Jun 7, 2023
Class
Kelas : 2
Risk Class
Kelas Resiko : B
HEMOCLOT Thrombin Inhibitors
Mar 2, 2023
Class
Kelas : 2
Risk Class
Kelas Resiko : B
REVOHEM ADP
Nov 18, 2022
Class
Kelas : 2
Risk Class
Kelas Resiko : B
REVOHEM™ Arachidonic Acid
Nov 16, 2022
Class
Kelas : 2
Risk Class
Kelas Resiko : B
REVOHEM Ristocetin
Oct 27, 2022
Class
Kelas : 2
Risk Class
Kelas Resiko : B
REVOHEM Epinephrine
Oct 27, 2022
Class
Kelas : 2
Risk Class
Kelas Resiko : B
About this profile

HYPHEN BIOMED. from France is a medical device manufacturer with 9 registered products in the Indonesia Ministry of Health database through Pure Global AI's free platform. The company produces 9 unique product types across 1 product class.

This page provides comprehensive manufacturer intelligence including complete product portfolio, risk class distribution, and product class analysis. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify manufacturers, analyze portfolios, and discover partnership opportunities efficiently.